Company: INMB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001213900-25-073077
Chunk: 159

Company: Inmune Bio, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part II, Item 1A
Chunk 159
---
mb:PITTAgreementMember

    2025-01-01
    2025-06-30

    0001711754
    
      us-gaap:TechnologyBasedIntangibleAssetsMember
      inmb:PITTAgreementMember

    2025-01-01
    2025-06-30

    0001711754
    
      us-gaap:MoneyMarketFundsMember
      us-gaap:FairValueMeasurementsRecurringMember

    2025-06-30

    0001711754
    
      us-gaap:MoneyMarketFundsMember
      us-gaap:FairValueInputsLevel1Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-06-30

    0001711754
    
      us-gaap:MoneyMarketFundsMember
      us-gaap:FairValueInputsLevel2Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-06-30

    0001711754
    
      us-gaap:MoneyMarketFundsMember
      us-gaap:FairValueInputsLevel3Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-06-30

    0001711754
    
      us-gaap:FairValueMeasurementsRecurringMember

    2025-06-30

    0001711754
    
      us-gaap:FairValueInputsLevel1Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-06-30

    0001711754
    
      us-gaap:FairValueInputsLevel2Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-06-30

    0001711754
    
      us-gaap:FairValueInputsLevel3Member
      us-gaap:FairValueMeasurementsRecurringMember

    2025-06-30

    0001711754
    
      us-gaap:USTreasuryBillSecuritiesMember
      us-gaap:FairValueMeasurementsRecurringMember

    2024-12-31

    0001711754
    
      us-gaap:USTreasuryBillSecuritiesMember
      us-gaap:FairValueInputs